Praxis Wins Creative Excellence Award
Praxis, a company specializing in centralized patient recruitment for clinical research studies, was recently awarded Best of Show as well as two Gold International Awards of Excellence (IN-AWE Awards) by the Healthcare Communication & Marketing Association (HCMA)
Praxis Wins International Best of Show for Creative Excellence
NASHVILLE, Tenn. – July 16, 2008– Praxis, a company specializing in centralized patient recruitment for clinical research studies, was recently awarded Best of Show as well as two Gold International Awards of Excellence (IN-AWE Awards) by the Healthcare Communication & Marketing Association (HCMA) at their annual conference in Dallas, TX, one of the healthcare advertising and marketing industry’s most prestigious honors. These awards are unique among healthcare awards because the judging criteria incorporate strategy and performance, as well as visual creative appeal. “Winning an IN-AWE Award has always stood as a testament of effective healthcare marketing. Taking home Best of Show was the piece de resistance, especially since our work was up against over 900 entries from top agencies across the world” says Donna Beasley, Vice President of Operations and Marketing, Praxis.
Praxis won Best of Show and a Gold award for a business-to-business marketing campaign – Have Patients! – Praxis earned a second Gold award for one of the campaign’s individual direct mail pieces. “Praxis’ brand has been built on creativity and effectiveness, not only for our own business building and awareness efforts but also for each of the unique recruitment campaigns we create specifically for our sponsor partners”, says Beasley.
Praxis Communications, Inc., headquartered in Brentwood, Tenn., provides the pharmaceutical and biotech industries with a wide range of global services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising and program management. For more information, call Praxis at (615)312-8207 or visit www.GoPraxis.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
